188 related articles for article (PubMed ID: 18295013)
1. Initial combination therapy in early Crohn's disease.
Sandborn WJ
Lancet; 2008 Feb; 371(9613):635-636. PubMed ID: 18295013
[No Abstract] [Full Text] [Related]
2. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
3. Early combined immunosuppression in Crohn's disease.
Badina L; Taddio A; Ventura A
Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555906
[No Abstract] [Full Text] [Related]
4. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
5. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Herrlinger KR; Stange EF
N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20825325
[No Abstract] [Full Text] [Related]
6. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
7. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Ruffolo C; Scarpa M; Bassi N
N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
[No Abstract] [Full Text] [Related]
8. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Gelber AC
N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20848680
[No Abstract] [Full Text] [Related]
9. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
D'Haens G; Baert F; van Assche G; Caenepeel P; Vergauwe P; Tuynman H; De Vos M; van Deventer S; Stitt L; Donner A; Vermeire S; Van De Mierop FJ; Coche JR; van der Woude J; Ochsenkühn T; van Bodegraven AA; Van Hootegem PP; Lambrecht GL; Mana F; Rutgeerts P; Feagan BG; Hommes D; ;
Lancet; 2008 Feb; 371(9613):660-667. PubMed ID: 18295023
[TBL] [Abstract][Full Text] [Related]
10. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
van den Brande JM; Peppelenbosch MP; Hommes DW
Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
[No Abstract] [Full Text] [Related]
11. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
Teichgräber U; Atreya I; Atreya R; Schwab M; Neurath MF
Inflamm Bowel Dis; 2013; 19(4):E54-5. PubMed ID: 22532373
[No Abstract] [Full Text] [Related]
12. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
Schreiber S
Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
[No Abstract] [Full Text] [Related]
13. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
14. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
15. Early combined immunosuppression in Crohn's disease.
Lees CW; Satsangi J
Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555905
[No Abstract] [Full Text] [Related]
16. Management of Crohn's disease--a practical approach.
Knutson D; Greenberg G; Cronau H
Am Fam Physician; 2003 Aug; 68(4):707-14. PubMed ID: 12952387
[TBL] [Abstract][Full Text] [Related]
17. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
[TBL] [Abstract][Full Text] [Related]
18. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
19. [Medical management of pediatric Crohn's disease].
Zeng Y; Gong S
Zhonghua Er Ke Za Zhi; 2014 May; 52(5):345-8. PubMed ID: 24969931
[No Abstract] [Full Text] [Related]
20. [Infliximab-induced hepatitis in a patient with Crohn's disease].
Soto-Fernández S; González-Carro P; De Pedro-Esteban A; Legaz-Huidobro ML; Pérez-Roldán F; Roncero García-Escribano O; Valbuena-González M; Ruiz-Carrillo F
Gastroenterol Hepatol; 2006 May; 29(5):321-2. PubMed ID: 16733041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
